Outlook Therapeutics Cash Flow Statement (2015-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-12.20M	-13.40M	-13.49M	-19.70M	-17.54M	-14.35M	-17.76M	-6.65M	-20.68M	-12.99M	-10.63M	-114.29M	44.41M	5.69M	-21.69M	-46.36M	-20.15M	-13.29M	-14.97M	-4.45M
Depreciation and Depletion (Quarter)	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M
Share-based Compensation (Quarter)	1.20M	1.40M	1.20M	3.76M	1.37M	1.38M	1.39M	1.38M	1.38M	1.39M	1.27M	1.31M	1.40M	1.41M	3.67M	1.70M	1.67M	1.82M	0.88M	3.27M
Gains from Investment Securities (Quarter)	0.03M	0.09M	-0.25M	0.03M	-0.23M	-0.01M	-0.03M	-0.02M	0.01M	-0.01M	0.05M	49.61M	-59.45M	-28.85M	-40.27M	-2.06M	2.00M	-2.68M	2.79M	-6.84M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)	-20.19M	-8.99M	-10.99M	-14.33M	-21.10M	-10.25M	-8.90M	-8.11M	-13.22M	-12.74M	-13.03M	-19.27M	-19.51M	-16.98M	-10.97M	-16.58M	-11.90M	-12.38M	-14.94M	-7.83M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.01M	0.01M	0.01M	0.01M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M
Change in Working Capital
Change in Receivables (Quarter)																		-0.26M	-1.38M	2.61M
Change in Inventory (Quarter)															3.11M	0.50M	0.52M	-0.79M	0.12M	-0.11M
Change in Account Payables (Quarter)	-3.49M	-0.39M	0.17M	1.79M	-1.68M	1.01M	0.68M	-0.55M	1.20M	1.76M	-3.09M	0.27M	1.69M	2.53M	4.22M	-4.63M	2.04M	0.03M	-2.87M	5.71M
Change in Accured Expenses (Quarter)	-1.00M	-1.77M	1.04M	-0.21M	-0.52M	-0.15M	5.01M	-2.22M	2.06M	-5.56M	1.34M	-1.00M	-0.41M	0.56M	0.15M	-0.99M	2.20M	0.35M	-0.30M	4.39M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	7.04M	-5.17M	0.29M	0.81M	3.37M	-1.37M	-0.79M	0.08M	-0.11M	-1.79M	2.45M	0.52M	3.04M	-1.10M	-5.63M	-0.21M	-0.33M	-1.84M	0.44M	2.18M
Investing Activities
Capital Expenditures (Quarter)										-0.02M			0.02M	-0.02M				1.00
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)		0.01M	0.02M	0.58M	-0.58M	0.58M	0.57M	0.25M										5.80M	0.60M
Cash from Financing Activities (Quarter)	2.72M	3.78M	66.66M	2.61M	-11.30M	1.63M	43.85M	-0.60M	3.30M	2.42M	-0.00M	56.14M	4.31M	-0.11M	1.74M	18.44M	13.25M	11.56M	15.53M	6.90M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)	3.20M	3.79M	57.65M	2.73M	0.29M	1.63M	24.64M	1.09M	3.43M	2.43M			4.31M	-0.11M	1.74M	1.42M	2.11M	8.09M	14.93M	6.90M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-17.48M	-5.21M	55.67M	-11.73M	-32.40M	-8.62M	34.94M	-8.71M	-9.92M	-10.32M	-13.04M	36.87M	-15.20M	-17.10M	-9.22M	1.85M	1.34M	-0.82M	0.59M	-0.93M
Free Cash Flow (Quarter)	-20.19M	-8.99M	-10.99M	-14.33M	-21.10M	-10.25M	-8.90M	-8.11M	-13.22M	-12.72M	-13.03M	-19.27M	-19.54M	-16.96M	-10.97M	-16.58M	-11.90M	-12.38M	-14.94M	-7.83M
Net Cash Flow (Quarter)	-17.48M	-5.21M	55.67M	-11.73M	-32.40M	-8.62M	34.94M	-8.71M	-9.92M	-10.32M	-13.04M	36.87M	-15.20M	-17.10M	-9.22M	1.85M	1.34M	-0.82M	0.59M	-0.93M

Research Tools

Datasets

Plans

Developers

Outlook Therapeutics OTLK Cash Flow Statement (2015-2026)

Research Tools

Datasets

Plans

Developers

Outlook Therapeutics OTLK Cash Flow Statement (2015-2026)

Create an account

Sign In

Reset Password